Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q1 EPS of $0.01, $0.31 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $64.5 million versus the consensus estimate of $64.39 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2024 EPS of ~($1.05), versus the consensus of ($1.06). Fulgent Genetics, Inc. sees FY2024 revenue of ~$280 million, versus the consensus of $279.4 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.